XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Operating expenses:    
Research and development expenses $ 1,551us-gaap_ResearchAndDevelopmentExpense $ 800us-gaap_ResearchAndDevelopmentExpense
General and administrative expenses 791us-gaap_SellingGeneralAndAdministrativeExpense 1,083us-gaap_SellingGeneralAndAdministrativeExpense
Operating loss 2,342us-gaap_OperatingIncomeLoss 1,883us-gaap_OperatingIncomeLoss
Financial (expense) income, net (535)us-gaap_OtherNonoperatingIncomeExpense 143us-gaap_OtherNonoperatingIncomeExpense
Net comprehensive loss before taxes 2,877us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 1,740us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Tax benefit (Note 5) 560us-gaap_IncomeTaxExpenseBenefit 0us-gaap_IncomeTaxExpenseBenefit
Net comprehensive loss $ 2,317us-gaap_NetIncomeLoss $ 1,740us-gaap_NetIncomeLoss
Net basic and diluted loss per share (in dollars per share) $ (0.04)us-gaap_EarningsPerShareBasicAndDiluted $ (0.04)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average number of ordinary shares used in computing basic and diluted net loss per share (in shares) 55,636,283us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 49,472,951us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted